Evolus (NASDAQ:EOLS) reported quarterly losses of $(0.30) per share which missed the analyst consensus estimate of $(0.17) by 76.47 percent. The company reported quarterly sales of $61.100 million which missed the analyst consensus estimate of $62.239 million by 1.83 percent. This is a 22.15 percent increase over sales of $50.019 million the same period last year.
Evolus Q3 2024 GAAP EPS $(0.30) Misses $(0.17) Estimate, Sales $61.100M Miss $62.239M Estimate
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated